Summary: The Centers for Medicare & Medicaid Services modified its HIV Testing (Diagnosis) coverage policy, effective May 15, 2026. Here's what billing teams need to do before that date.
CMS HIV testing coverage policy has been updated under this modified determination. The policy does not list a specific policy code. This change affects how Medicare handles diagnostic HIV testing claims — and if your practice bills for HIV screening or confirmatory diagnostics, you need to review your documentation standards and charge capture before May 15, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Human Immunodeficiency Virus (HIV) Testing (Diagnosis) |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | 2026-05-15 |
| Impact Level | High |
| Specialties Affected | Infectious Disease, Internal Medicine, Primary Care, OB/GYN, Urgent Care, Clinical Laboratory |
| Key Action | Review diagnostic HIV testing documentation and billing guidelines against the updated coverage criteria before May 15, 2026. |
CMS HIV Testing Coverage Criteria and Medical Necessity Requirements 2026
The full text of the updated CMS HIV testing coverage policy was not available at the time of publication. The policy documents provided for this change do not include the specific criteria or updated language. Because of that, this post does not reproduce coverage criteria — doing so would mean inventing language that may not match what CMS actually published.
That matters. With HIV testing billing, the difference between a diagnostic test and a screening test drives everything — the codes you use, the documentation you need, and whether the claim pays at all.
Here's what we know from how CMS has historically structured HIV testing coverage policy and what billing teams should verify directly against the updated document.
Diagnostic vs. Screening: The Core Distinction
CMS has long treated HIV screening and HIV diagnostic testing differently. Screening is typically covered under the preventive benefit — Medicare covers HIV screening for beneficiaries at increased risk, and the Affordable Care Act made it a zero-cost-sharing preventive service. Diagnostic testing is a separate bucket. It applies when a patient has signs or symptoms, a known exposure, or a clinical reason to suspect infection.
The distinction drives code selection and medical necessity documentation. If CMS modified this coverage policy, the most likely areas of change involve the criteria for when diagnostic testing meets medical necessity — not screening, which is governed by a separate benefit structure.
Prior Authorization and Medical Necessity
CMS does not typically require prior authorization for HIV diagnostic testing under Medicare fee-for-service. However, Medicare Advantage plans operate under their own rules. If your patients are covered by an MA plan, check that plan's HIV testing prior authorization requirements separately — they are not governed by this CMS determination.
For fee-for-service Medicare, medical necessity documentation is what drives reimbursement. Your clinical notes need to support the reason for diagnostic HIV testing. "Routine" is not a diagnosis. If the test is diagnostic, your documentation needs to show why.
Local Coverage Determinations Still Apply
This change is at the national level. But your Medicare Administrative Contractor may have a local coverage determination that adds requirements on top of this national policy. Check with your MAC before assuming the national change is all you need to follow. Regional variation in HIV testing LCD coverage is real, and a claim denial based on an LCD you didn't check is entirely avoidable.
Coverage Indications at a Glance
The policy data provided for this change does not include indication-level coverage criteria. The table below reflects the general CMS framework for HIV testing coverage as it has historically applied. Verify each row against the actual updated policy document before using this as a billing reference.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Diagnostic HIV testing with documented signs/symptoms or known exposure | Generally Covered | Verify with updated policy | Medical necessity documentation required |
| HIV screening for at-risk beneficiaries | Covered (Preventive) | Separate preventive benefit | Zero cost-sharing; governed by different benefit category |
| Confirmatory testing following reactive initial result | Generally Covered | Verify with updated policy | Clinical rationale must be documented |
| Routine testing without clinical indication | Generally Not Covered under diagnostic benefit | N/A | May be billable under preventive benefit if criteria met |
| HIV testing in pregnancy | Generally Covered | Verify with updated policy | OB/GYN billing teams should confirm under updated policy |
All rows above reflect general CMS framework, not the specific updated policy language. Verify against the official updated document at the CMS source link.
CMS HIV Testing Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Pull the actual updated policy document before May 15, 2026. The source URL for this change is https://app.payerpolicy.org/p/cms/53-v3. Read the updated language yourself. Don't rely on summaries — including this one — when the actual document is available. |
| 2 | Audit your charge capture for HIV diagnostic testing codes. The policy does not list specific codes in the data provided. That means you need to confirm which codes your practice currently uses for diagnostic HIV testing and verify they still map correctly to the updated coverage criteria. Run a charge capture audit against the last 90 days of HIV testing claims. |
| 3 | Separate your diagnostic and screening claims cleanly. If your billing team uses the same workflow for HIV screening and HIV diagnostic testing, fix that before the effective date. The coverage policy governs diagnostic testing. Screening claims follow a different path. Mixing them generates claim denials that are hard to unravel on appeal. |
| 4 | Update your medical necessity documentation templates. If your EHR has order templates or documentation templates for HIV testing, make sure they prompt clinicians to document the clinical reason for diagnostic testing. "Per patient request" or no indication at all will not support reimbursement under a diagnostic benefit. |
| 5 | Check your MAC's LCD for HIV testing. Your Medicare Administrative Contractor may have issued or updated a local coverage determination that interacts with this national policy change. Contact your MAC or check their website directly. Don't assume the national policy is the only rule in play. |
| 6 | Review HIV testing billing guidelines for Medicare Advantage plans in your payer mix. MA plans set their own prior authorization requirements and coverage rules. This CMS change governs traditional Medicare. If a significant portion of your HIV testing volume comes from MA beneficiaries, check each plan's current HIV testing coverage policy separately. |
| 7 | If your practice has high HIV testing volume, talk to your compliance officer before May 15, 2026. A modification to a CMS coverage policy can shift what documentation auditors look for retroactively on post-payment review. Your compliance officer should review the updated policy and assess whether your current documentation practices hold up. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for HIV Testing Under This Policy
The policy data provided for this change does not include specific CPT, HCPCS, or ICD-10 codes. This is not unusual for a modified CMS policy — the code mapping often lives in the LCD or in the claims processing instructions rather than the coverage policy itself.
Do not use invented codes. The right move here is to verify the code set directly against the updated policy document and your MAC's LCD.
What to Look For When You Pull the Document
When you access the updated policy, confirm the following:
- Which CPT codes are explicitly listed as covered for HIV diagnostic testing
- Whether any codes have been added, removed, or had their coverage status changed in this modification
- Which ICD-10-CM diagnosis codes support medical necessity for diagnostic HIV testing claims
- Whether any codes have been reclassified as experimental or non-covered
Common Code Families Associated With HIV Testing (For Reference Only)
The policy data does not list codes. The following are code families commonly associated with HIV testing in Medicare billing. Confirm these against the actual updated policy before using them as a billing reference.
HIV testing codes typically fall in the CPT 86000-series (immunology) and 87000-series (microbiology/virology) families. Confirmatory testing may involve additional codes. ICD-10-CM codes in the Z71.7 (HIV counseling), Z21 (asymptomatic HIV infection status), and B20 (HIV disease) ranges are commonly associated with HIV testing claims.
None of these are confirmed codes from the updated policy. Treat this paragraph as orientation, not as billing guidance.
Get the Full Picture for CPT 86000
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.